Marathon Trading Investment Management »

Tscan Therapeutics shares owned by Marathon Trading Investment Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Marathon Trading Investment Management from 13F filings

Historical chart of Marathon Trading Investment Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Marathon Trading Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Marathon Trading Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $80k 14k 5.85
2024-03-31 $405k 51k 7.94

More positions owned by Marathon Trading Investment Management

Spdr S&p 500 Etf Tr Option Put Option
Ishares Tr Option Call Option
Bank America Corp Option Put Option
United States Stl Corp Option Put Option
Bank America Corp Common Stock (BAC)
United States Stl Corp Option Call Option
Citigroup Option Put Option
Invesco Qqq Tr Option Put Option
Citigroup Common Stock (C)
Spdr Gold Tr Option Call Option
Pdd Holdings Option Put Option
Spdr Gold Tr Option Put Option
Vaneck Etf Trust Option Put Option
Jd.com Option Call Option
Ishares Tr Common Stock (EEM)

View all positions for Marathon Trading Investment Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BlackRock
BlackRock
BVF
Baker Bros. Advisors
Vanguard Group
Propel Bio Management
Deer Management
Alphabet
Simplify Asset Management
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Stempoint Capital
DC Funds

View all funds holding Tscan Therapeutics